The rate of severe cases and mortality of COVID-19 in Hunan are lower than those in Wuhan. In addition to antivirals and oxygen support, timely interventions including corticosteroids, immunoglobulin, and antibiotics, contribute to improving the prognosis of severe COVID-19 patients.
Keyphrases
- coronavirus disease
- sars cov
- early onset
- end stage renal disease
- respiratory syndrome coronavirus
- physical activity
- newly diagnosed
- ejection fraction
- peritoneal dialysis
- chronic kidney disease
- risk factors
- cardiovascular events
- cardiovascular disease
- prognostic factors
- drug induced
- coronary artery disease
- patient reported outcomes
- patient reported